Data and safety monitoring committees in clinical trials /

Saved in:
Bibliographic Details
Author / Creator:Herson, Jay.
Imprint:Boca Raton, FL : Chapman & Hall/CRC, c2009.
Description:xviii, 173 p. : ill. ; 25 cm.
Language:English
Series:Chapman & Hall/CRC biostatistics series ; 30
Subject:Drugs -- Testing -- Evaluation.
Drugs -- Testing -- Statistical methods -- Evaluation.
Clinical Trials Data Monitoring Committees -- organization & administration.
Clinical Trials as Topic -- standards.
Data Collection.
Drug Industry -- standards.
Research Design.
Safety Management.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/7733614
Hidden Bibliographic Details
ISBN:9781420070378 (hardcover : alk. paper)
1420070371 (hardcover : alk. paper)
Notes:Includes bibliographical references (p. 155-166) and index.
LEADER 02192cam a22004694a 4500
001 7733614
003 ICU
005 20100127152300.0
008 090127s2009 flua b 001 0 eng
010 |a  2009003127 
020 |a 9781420070378 (hardcover : alk. paper) 
020 |a 1420070371 (hardcover : alk. paper) 
035 |a 2009003127 
035 |a (OCoLC)166872492 
040 |a DNLM/DLC  |c DLC  |d YDX  |d NLM  |d BTCTA  |d BAKER  |d YDXCP  |d UtOrBLW 
042 |a pcc 
050 0 0 |a RM301.27  |b .H47 2009 
060 1 0 |a QV 771  |b H572d 2009 
082 0 0 |a 615/.19  |2 22 
100 1 |a Herson, Jay.  |0 http://id.loc.gov/authorities/names/n2009180361  |1 http://viaf.org/viaf/61031991 
245 1 0 |a Data and safety monitoring committees in clinical trials /  |c Jay Herson. 
260 |a Boca Raton, FL :  |b Chapman & Hall/CRC,  |c c2009. 
300 |a xviii, 173 p. :  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Chapman & Hall/CRC biostatistics series ;  |v 30 
504 |a Includes bibliographical references (p. 155-166) and index. 
505 0 |a Introduction -- Organization of a safety monitoring program for a confirmatory trial -- Meetings -- Clinical issues -- Statistical issues -- Bias and pitfalls -- Data monitoring committee decisions -- Emerging issues. 
650 0 |a Drugs  |x Testing  |x Evaluation. 
650 0 |a Drugs  |x Testing  |x Statistical methods  |x Evaluation. 
650 1 2 |a Clinical Trials Data Monitoring Committees  |x organization & administration. 
650 1 2 |a Clinical Trials as Topic  |x standards. 
650 2 2 |a Data Collection. 
650 2 2 |a Drug Industry  |x standards. 
650 2 2 |a Research Design. 
650 2 2 |a Safety Management. 
903 |a HeVa 
929 |a cat 
999 f f |i 53b47cdc-7a04-52ab-a826-02d3fe45975a  |s 7e0fd2da-96a6-5b7f-8598-93126fe4ad01 
928 |t Library of Congress classification  |a RM301.27 .H47 2009  |l JCL  |c JCL-Sci  |i 5473758 
927 |t Library of Congress classification  |a RM301.27 .H47 2009  |l JCL  |c JCL-Sci  |e CRERAR  |b 089356666  |i 8626151